Clinical Trial Update: International Study on Treatment of Liver (HCC) Patients With IRE [NA]

View source ↗

Summary

Clinical trial status update indicates an international study evaluating irreversible electroporation for hepatocellular carcinoma is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Angiodynamics, Inc. | Conditions: Hepatocellular Carcinoma (HCC), Liver Ablation | NA | Status: NOT_YET_RECRUITING